Knee Osteoarthritis

Degenerative joint disease of the knee characterized by progressive articular cartilage loss, subchondral bone remodeling, osteophyte formation, and chronic pain with functional impairment.

2. Epidemiology

3. Risk Factors

Risk factors for KOA can be broadly categorised [1][2][3]:

4. Anatomy and Function of the Knee Joint

Understanding the anatomy is essential to understanding why OA affects the knee the way it does.

5. Pathophysiology

5.3 Molecular Biology of KOA

Biology of OA Knee — the molecular cascade [5]:

This is a complex interplay between mechanical stress, inflammation, and failed repair:

6. Classification

7. Clinical Features

7.1 Symptoms

7.2 Signs

8. Radiological Features

Differential Diagnosis of Knee Osteoarthritis

When a patient walks into your clinic with a painful, stiff knee, your job is not to jump straight to "OA knee." Your job is to systematically consider what else could be causing this presentation, then use the history, examination, and investigations to narrow down. Think of it this way: "knee pain" is the symptom — OA is only one of many possible diagnoses.

The differential diagnosis of KOA is best approached by considering:

  1. Anatomical location of the pain (anterior, medial, lateral, posterior)
  2. Acuity (acute injury vs chronic/insidious)
  3. Category of pathology (degenerative, inflammatory, crystal, infective, traumatic, referred, neoplastic)

1. Approach by Anatomical Location

Differential Diagnosis of Knee Pain by Anatomic Site [1]:

This is a classic framework and is very high-yield. The knee is a large, complex joint, and different structures live in different compartments. The location of pain gives you a strong clue.

2. Approach by Category of Pathology

This is the more systematic approach for exams — thinking through the broad categories of "what causes a painful, stiff knee?"

References

[1] Lecture slides: GC 228. Knee Osteoarthritis_Part A (1).pdf (p16–p22, p32–p33) [2] Senior notes: maxim.md (section 9.1 Osteoarthritis) [3] Senior notes: maxim.md (section 6.3 OA hip) [6] Senior notes: maxim.md (sections 7.2 Soft tissue injuries, 7.3 Bone and joint injuries — ACL tear, MCL/LCL, meniscal tear, ITB syndrome, patella dislocation, tibial plateau fracture) [7] Lecture slides: GC 230. Knee Sport Injuries_Part 3.pdf (p16, p18, p27) [8] Senior notes: felixlai.md (Baker's cyst, sciatica, chronic compartment syndrome)

Diagnostic Criteria, Algorithm, and Investigations for Knee Osteoarthritis

1. Diagnostic Criteria

There is no single "gold standard" laboratory test for OA — the diagnosis is fundamentally clinical + radiographic. Unlike RA (which has formal ACR/EULAR classification criteria with serological markers), OA diagnosis relies on the constellation of history, examination, and imaging findings. Let's go through the two most widely used criteria sets.


1.1 ACR Clinical Classification Criteria for OA of the Knee (1986/1991)

The American College of Rheumatology developed these criteria specifically for classifying KOA. They exist in three formats — clinical alone, clinical + radiographic, and clinical + laboratory. The clinical + radiographic version is the most commonly used and the most relevant for exams.

3. Investigation Modalities

3.1 Plain Radiography (X-ray) — The Cornerstone

Workup of Knee Osteoarthritis [1] — X-ray is the first-line and most important imaging modality.

3.2 Advanced Imaging

3.3 Laboratory Investigations

OA is a clinical-radiographic diagnosis — laboratory tests are used to exclude other diagnoses, not to confirm OA.

References

[1] Lecture slides: GC 228. Knee Osteoarthritis_Part A (1).pdf (p2, p13, p22, p28, p32, p33) [2] Senior notes: maxim.md (sections 7.4 OA knee, 9.1 Osteoarthritis) [5] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p13) [7] Lecture slides: GC 230. Knee Sport Injuries_Part 3.pdf (p27)

Management of Knee Osteoarthritis

1. Non-Pharmacological Management (First Line — FOR ALL)

The core non-pharmacological Mx of Knee OA [1]:

Core priority treatments for OA include exercise and physical activity, weight-loss, education and support for self-management [9].

2. Pharmacological Management (Second Line — SOME)

Pharmacological Mx of Knee Osteoarthritis [9]:

The key principle: pharmacological treatment does NOT modify the disease course — it manages symptoms. Not affect natural history [10]. All drugs are symptomatic relief only.

3. Surgical Management (Third Line — FEW)

Surgical Mx of Knee Osteoarthritis [9]:

Surgery is indicated when:

  • Patient factor: age, functional status [2]
  • Disease factor: severe impairment to ADL, pain despite conservative treatment [2]
  • The key principle: surgery is for patients who have FAILED adequate conservative management (at least 3–6 months of optimised non-pharmacological + pharmacological treatment).

Enhanced recovery after surgery (ERAS) protocol [11]:

  • MSSA screening: de-colonisation x 1 week [11]
  • Pre-op analgesics [11]
  • Dexamethasone on call to OT (16mg IV stat) [11]
  • HbA1c control: < 8 [11]
  • Confirm definite discharge plan: 1 month full-time carer after TKA [11]

References

[1] Lecture slides: GC 228. Knee Osteoarthritis_Part A (1).pdf (p2, p11, p34, p35, p36, p42, p43) [2] Senior notes: maxim.md (sections 7.4 OA knee, 9.1 Osteoarthritis) [5] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p12) [9] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p2, p8, p10, p13, p15, p18, p19, p28, p29, p30, p31) [10] Lecture slides: GC 229. Hip Arthritis (1).pdf (p34, p37, p38, p39) [11] Senior notes: maxim.md (section 1.3 Management overview — ERAS)

Complications of Knee Osteoarthritis

Complications of KOA can be divided into two broad categories: (A) complications of the disease itself (what happens if OA progresses untreated or inadequately treated), and (B) complications of treatment (particularly surgical complications, which are heavily tested in exams). Let's go through both systematically.


A. Complications of the Disease Itself

B. Complications of Treatment

4. Complications of Arthroplasty (UKA and TKR)

These are the most commonly tested complications and are categorised by timing:

References

[1] Lecture slides: GC 228. Knee Osteoarthritis_Part A (1).pdf (p5) [2] Senior notes: maxim.md (sections 7.4 OA knee, 9.1 Osteoarthritis) [5] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p13) [6] Senior notes: maxim.md (section 7.2 Soft tissue injuries — complications of knee arthroscopy) [9] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p8, p10, p17, p18, p23, p29) [12] Senior notes: maxim.md (section 9.1 Osteoarthritis — specific complications of total replacement, post-op)

High Yield Summary

Definition: KOA = whole-joint disease (not just cartilage) involving cartilage degradation, subchondral bone remodelling, osteophyte formation, and synovitis in the three knee compartments.

Epidemiology: ~1 billion affected globally by 2050. In Hong Kong, 40% population > 65 by 2050. KOA increases mortality via CV disease, depression, immobility.

Risk Factors: Age, female sex, obesity (mechanical + metabolic), previous trauma, occupation, malalignment, muscle weakness, genetics. Secondary causes in young patients — always look for a cause.

Pathophysiology: Catabolic > anabolic. ADAMTS + MMPs degrade cartilage matrix → cartilage fragments trigger synovitis → IL-1, IL-6, TNF → more MMP release → vicious cycle. Subchondral bone sclerosis and osteophytes are failed repair attempts.

Aging vs OA (High Yield Table): In aging, both synthesis and degradation decrease. In OA, degradation markedly increases while synthesis increases insufficiently → net cartilage loss.

Clinical Features: Pain (worse with activity, better with rest; going downstairs = patellofemoral), stiffness ( < 30 min), swelling, deformity (genu varum most common), crepitus, reduced ROM. Extension lag (muscle) vs fixed flexion contracture (structural).

Radiology — LOSS: Loss of joint space (earliest), Osteophytes, Subchondral sclerosis, Subchondral cysts. Always weight-bearing AP + skyline. KL grading: Grade 2 = definite OA, Grade 4 = bone-on-bone.

Key Distinction: OA = preserved bone density, osteophytes, no erosions. RA = osteopenia, erosions, no osteophytes.

High Yield Summary

Anatomical approach to DDx of knee pain: Anterior (patellofemoral syndrome, patellar tendonitis, Osgood-Schlatter, prepatellar bursitis), Medial (MCL sprain, medial meniscal tear, pes anserine bursitis, medial plica), Lateral (LCL sprain, lateral meniscal tear, ITB syndrome), Posterior (Baker's cyst, PCL injury).

Category approach: Degenerative (OA, degenerative meniscal tear), Inflammatory (RA, PsA, AS), Crystal (gout, CPPD), Infective (septic arthritis — EMERGENCY, TB), Traumatic (ACL/meniscal/ligament tears, fractures), Periarticular (bursitis, tendonitis), Referred (hip OA, lumbar radiculopathy), Neoplastic (osteosarcoma, PVNS).

Critical distinctions: (1) Varus deformity = OA, Valgus = RA. (2) Stiffness < 30 min = OA, > 60 min = RA. (3) LOSS features on X-ray = OA; erosions + osteopenia = RA; chondrocalcinosis = CPPD. (4) Always examine the hip when knee exam is normal — referred pain via obturator nerve. (5) Degenerative meniscal tears on MRI in OA patients are often incidental — don't operate unless mechanical symptoms (locking). (6) Acute hot joint = septic arthritis until proven otherwise — aspirate.

Swelling timing post-injury: Immediate = haemarthrosis (ACL, fracture); Delayed 6–12h = meniscal tear; Chronic = OA.

High Yield Summary

Diagnostic criteria: ACR clinical + radiographic criteria = knee pain + age > 50 / stiffness < 30 min / crepitus + osteophytes on X-ray. NICE 2022: age ≥ 45, activity-related pain, no/brief stiffness → diagnose clinically without imaging.

First-line imaging: Weight-bearing AP and lateral X-rays. Always weight-bearing! Add skyline for PFJ, Schuss view for early OA, standing scanogram for alignment (surgical planning).

LOSS features: Joint space narrowing (earliest), Osteophytes, Subchondral sclerosis, Subchondral cysts. Grade with Kellgren-Lawrence (KL 2 = definite OA, KL 4 = bone-on-bone).

MRI role: Early detection (pre-radiographic stage), assessing meniscal/ligament integrity, pre-operative planning (UKA needs intact ACL). Beware incidental degenerative meniscal tears — don't operate unless mechanical symptoms.

Labs: Not needed for typical KOA. Done to EXCLUDE mimics: ESR/CRP (inflammation), RF/anti-CCP (RA), urate (gout), joint aspirate (infection/crystals). OA synovial fluid: clear, viscous, WBC < 2,000/mm³.

Key principle: Treat the patient, not the X-ray — radiographic severity does not always correlate with symptoms.

High Yield Summary

Treatment pyramid: (1) ALL patients → Education, Exercise, Weight loss (the TRIAD). (2) SOME patients → Pharmacological (topical NSAIDs first, then oral NSAIDs with PPI; paracetamol has limited benefit; opioids NOT recommended; IA steroid for flares). (3) FEW patients → Surgery.

First-line management is NOT analgesics — it is weight reduction, education and exercise.

Paracetamol: Network meta-analysis shows no demonstrable benefit in OA at any dose. Paradigm shift from traditional teaching.

Opioids: Very limited role. Worsen surgical outcomes, cause falls/fractures in elderly, addiction risk. Not recommended by updated guidelines.

Arthroscopy in OA: Limited indication ONLY for frequent locking from meniscal tears/loose bodies. Increases rate of OA progression. Shortens time to joint replacement. NOT for debridement/lavage.

Surgical options: HTO (young, single compartment, correctable deformity), UKA (Oxford criteria: medial bone-on-bone + intact ACL + intact MCL + full lateral cartilage + acceptable PFJ), TKR (multicompartment, FFD ≥ 10°, arc ≤ 110°, failed conservative).

Oxford UKA 5 criteria: (1) Medial bone-on-bone, (2) Functionally intact ACL, (3) Functionally intact MCL, (4) Full thickness lateral cartilage, (5) Acceptable PFJ.

ERAS protocol: MSSA screening + decolonisation, pre-op analgesics, dexamethasone IV, HbA1c < 8, confirmed discharge plan.

High Yield Summary

Disease complications: Progressive deformity (varus most common), fixed flexion contracture, quadriceps wasting (arthrogenic inhibition), loss of function/disability, Baker's cyst (± rupture mimicking DVT), secondary meniscal/ligament degeneration, falls/fractures, central pain sensitisation. Systemic: increased CV/respiratory risk, depression, sleep disturbance, increased mortality — OA is a SERIOUS disease.

Treatment complications:

  • NSAIDs: GI bleeding, renal impairment, CV events.
  • Paracetamol: liver function abnormalities, especially in elderly.
  • Opioids: addiction, sedation/falls, worse surgical outcomes.
  • Arthroscopy in OA: DVT/PE/death, accelerates OA progression, shortens time to TKR. No evidence for debridement/chondroplasty.
  • TKR specific complications: Immediate (fracture, popliteal artery injury, CPN palsy), Early (DVT/PE, infection — difficult to detect and treat), Late (LLD — must counsel, prosthesis infection, patellar instability, aseptic loosening, periprosthetic fracture).
  • UKA is safer perioperatively (lower rates of wound complications, MI, PE, infection, stiffness) but has higher revision rate than TKR.
  • Prosthesis survival: 15–20 years.

On this page

No Headings